Kiwoom KIWOOM US Blockbuster Biotech Drugs Plus ETF (483030)

Seoul
Currency in KRW
9,200
-145(-1.55%)
Delayed Data·

483030 Holdings and Weightings

Top 10 Holdings

LLY11.28%771.75-3.45%915
JNJ10.19%155.17-1.05%4,694
MRK10.13%81.52-2.57%8,593
SNY9.53%48.12-0.89%12,737
ABBV9.45%186.39-2.68%3,508
NVO8.13%67.22-2.49%8,959
AMGN6.09%292.51-1.52%1,517
NVS5.74%119.67-1.13%3,635
AZN5.39%70.32-1.98%5,402
BMY5.14%46.43-1.92%7,506

Assets Allocations

Stocks102.28%
Cash (Short)3.05%
Cash0.77%

Sector Allocation

Name
% Weight
Healthcare100.00%

Region Allocation

Name
% Weight
North America63.25%
Europe Developed32.87%
Asia3.88%

FAQ

What are the total assets under management (AUM) of 483030 ETF?

The total assets under management (AUM) for 483030 ETF are 3.18B.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.